Bad pharma: trafficking illicit medical products in West Africa

Flore Berger; Mouhamadou Kane

Attachments [ 0 ]

There are no files associated with this item.

More Details

Date of Issue Thu, 14 Sep 2023 00:00:00 +0200

Note

Pour la version française cliquez ici

Para a versão em português clique aqui

West Africa has become a hotspot for the trafficking of medical products, with estimations that the illicit market makes up to 80% of medical products in Burkina Faso and Guinea, the two case studies of this report. Despite its enormous scale, there are gaps in knowledge that this report seeks to address by providing a qualitative analysis of the market’s key characteristics and enablers (corruption and insecurity), and an assessment of national and regional responses.

About the authors

Flore Berger is an analyst in the Observatory of Illicit Economies in West Africa at the Global Initiative Against Transnational Organized Crime (GI-TOC), with a geographic focus on Mali and Burkina Faso.

Mouhamadou Kane is an analyst in the Observatory of Illicit Economies in West Africa at GI-TOC, with a geographic focus on Senegal and Guinea.

Abstract

This report analyses the market's key characteristics and enablers and assesses national and regional responses.